The global microbial identification market is experiencing significant growth fueled by multiple factors, according to a comprehensive study aimed at unraveling the various facets of this dynamic industry. The insights presented in the report are expected to provide valuable guidance for assessing market growth during the forecast period.

Surging Prevalence of Infectious Diseases Will Uphold Microbial Identification Market Growth

The increasing prevalence of infectious diseases, coupled with technological advancements in microbial identification, growing concerns regarding food safety, and government initiatives and funding for enhancing microbial identification processes, are driving the expansion of the microbial identification market. The primary catalyst for market growth is the rise in infectious diseases, with regions such as South-East Asia, Africa, and the Western Pacific being particularly affected. This surge in infectious disease cases is expected to boost the demand for microbiological testing, driving rapid market growth.

The escalating concerns about food safety, especially in processed and packaged foods, are also contributing to industry expansion. With a significant portion of the population shifting towards processed foods, the risk of microbial contamination in these products has increased. This shift in dietary habits is expected to elevate the need for microbiological testing to ensure the production of safe and high-quality food, further driving the growth of the microbial identification market.

Microbial Identification Market: COVID-19 Impact

The COVID-19 pandemic, declared a global health crisis, resulted in nationwide lockdowns and restrictions on international travel. Consequently, the sales of consumables and instruments required for microbiological identification were significantly impacted in most countries, adversely affecting the microbial identification market. However, the market is expected to recover gradually. During the pandemic, advancements such as the use of MALDI-TOF MS profiling for identifying distinctive protein signatures in human saliva to diagnose COVID-19 demonstrated the adaptability of microbial identification technologies. This adaptability is expected to contribute to the market’s growth in the coming years.

Growing Prevalence of Pandemics, and Rising Incidence of Infectious Diseases to Foster Microbial Identification Market Expansion

Microbial identification plays a critical role in the diagnosis of human diseases, enabling the rapid and accurate implementation of effective treatments. With approximately 1,400 pathogens capable of harming humans, and millions of foodborne illnesses and deaths occurring globally, the significance of microbial identification cannot be overstated. Infectious diseases, including tuberculosis and HIV/AIDS, continue to pose significant threats, driving the demand for advanced microbial identification solutions.

Pharmaceutical Research Advancements to Drive Microbial Identification Market Growth

The pharmaceutical industry’s success relies on its ability to address modern medical challenges. Pharmaceutical companies are increasingly embracing microbial identification to foster innovation in drug development and research. Additionally, microbial identification is instrumental in studying human DNA and its variations, further contributing to the growth of the microbial identification market.

Expensive Costs of Automated Identification Technologies Limits Market Growth

While automated microbiological identification tools offer advanced features and capabilities, their high costs pose a challenge to market expansion. Systems such as MALDI-TOF-based systems can cost between US$150,000 to US$850,000, making them less accessible for some end-users. The expenses associated with consumables and labor further add to the overall cost of microbial identification. These cost factors limit the widespread adoption of automated microbial identification techniques, especially among smaller institutions, thereby restraining market growth.

Bacterial Identification Systems to Dominate Microbial Identification Market

In the product segment, bacterial identification systems currently hold the largest market share and are expected to witness significant growth. These systems are widely used across various industries, including food quality assurance and clinical microbiology labs. They offer advantages such as reduced labor requirements, lower risk of human error, increased sample throughput, and faster test results compared to traditional methods.

Phenotypic Methods Category to Dominate Microbial Identification Market

Among the different identification methods, phenotypic methods dominate the microbial identification market. These methods rely on expressed gene products to differentiate between various bacteria. They are extensively used in clinical, water, food, and pharmaceutical microbiological testing laboratories.

North America’s Prominence Prevails in Microbial Identification Market

North America is expected to account for the largest revenue share in the microbial identification market during the forecast period. Factors such as the rising prevalence of infectious diseases, increasing healthcare expenditures, and a well-established healthcare infrastructure are driving market growth in the region. Rising healthcare spending is expected to support innovation and government efforts to develop cutting-edge testing solutions, further fueling market expansion.

The Asia Pacific microbial identification market is projected to experience stable revenue growth due to growing consumer concerns regarding health and food safety, government initiatives, and expanding healthcare infrastructure. China, in particular, is emerging as a significant market due to the increasing prevalence of infectious diseases.

Global Microbial Identification Market: Competitive Landscape

Key players in the microbial identification market include Danaher Corporation, Bruker Corporation, Thermo Fisher Scientific, Siemens Healthineers, Shimadzu Corporation, QIAGEN N.V, bioMerieux S.A., Merck & Co Inc., Biolog, Inc., Becton, Dickinson and Company, Beckman Coulter, Wickham Laboratories, VWR International, LLC., MIDI Inc., Siemens Healthcare, and Charles River Laboratories Inc.

Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/microbial-identification-market

Our Blogs:

https://issuu.com/fmrresearch/docs/mortgage_lending_market_set_to_skyrocket_with_a_pr

https://www.pearltrees.com/reportsinsights#item544457839

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

Contact

Fairfield Market Research

London, UK

UK +44 (0)20 30025888

USA (Toll-free) +1 (844) 3829746

Web: https://www.fairfieldmarketresearch.com/

Email: sales@fairfieldmarketresearch.com

LinkedIn | Twitter

This press release first seen on Brilad